Mehdi Saberian, Hossein Hamzeiy, Ayuob Aghanejad, Davoud Asgari*
|
Mehdi Saberian-Borujeni, Mohammad Johari-Ahar, Hossein Hamzeiy, Jaleh Barar  , Yadollah Omidi*
|
Mohsen Ebrahimi, Mohammad Johari-Ahar, Hossein Hamzeiy*, Jaleh Barar , Omid Mashinchian, Yadollah Omidi*
|
Ayuob Aghanejad, Hiwa Babamiri, Khosro Adibkia, Jaleh Barar , Yadollah Omidi*
|
Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar , Yadollah Omidi*
Aptamers (Aps) are short single-strand nucleic acids, which can be used as the therapeutic and targeting agent in advanced drug delivery systems. Conjugation of Aps with other entities (siRNA, toxins, drugs, DNAzyme/Ribozymes) provides advanced multifunctional nanosystems for cancer therapy.
|
Mitra Torabi , Ayuob Aghanejad*, Pouria Savadi , Abolfazl Barzegari, Yadollah Omidi , Jaleh Barar*
Owing to their unique advantages, mesoporous silica nanoparticles (MSNPs) have attracted much attention for drug delivery and targeting. In the current study, MSNPs were fabricated, PEGylated, loaded with sunitinib, and conjugated with mucin-16 aptamer to target CA125 on ovarian cancer cells.
|